INTEGRA LIFESCIENCES HOLDINGS CORPORATION Integra LifeSciences Holdings Corporation Stock
Equities
IART
US4579852082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.54 USD | +0.18% |
|
+5.96% | -36.76% |
| May. 17 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
| May. 17 | Integra LifeSciences Holdings to Repurchase $50 Million in Shares | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 1.68B | Sales 2025 * | 1.77B | Capitalization | 2.17B |
|---|---|---|---|---|---|
| Net income 2024 * | 95M | Net income 2025 * | 157M | EV / Sales 2024 * | 2.07 x |
| Net Debt 2024 * | 1.29B | Net Debt 2025 * | 1.44B | EV / Sales 2025 * | 2.04 x |
| P/E ratio 2024 * |
24.2
x | P/E ratio 2025 * |
14.9
x | Employees | 3,946 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.14% |
More Fundamentals
* Assessed data
More news
Latest transcript on Integra LifeSciences Holdings Corporation
More recommendations
More press releases
More news
| 1 day | +0.18% | ||
| 1 week | +5.96% | ||
| Current month | -5.59% | ||
| 1 month | -12.93% | ||
| 3 months | -38.85% | ||
| 6 months | -28.93% | ||
| Current year | -36.76% |
1 week
26.02
28.23
1 month
22.3629.96
Current year
22.3645.42
1 year
22.3650.78
3 years
22.3676.70
5 years
22.3677.40
10 years
22.0077.40
| Managers | Title | Age | Since |
|---|---|---|---|
Jan de Witte
CEO | Chief Executive Officer | 59 | 21-11-30 |
Lea Knight
DFI | Director of Finance/CFO | 52 | 23-06-27 |
Stuart Essig
CHM | Chairman | 62 | 97-11-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jeffrey Graves
BRD | Director/Board Member | 62 | Dec. 11 |
Stuart Essig
CHM | Chairman | 62 | 97-11-30 |
Christian Schade
BRD | Director/Board Member | 63 | 05-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.75% | 2 M€ | +10.27% | ||
| 0.71% | 8 M€ | +5.66% | ||
| 0.20% | 430 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 27.54 | +0.18% | 835,428 |
| 24-05-16 | 27.49 | +3.85% | 968,059 |
| 24-05-15 | 26.47 | +0.11% | 715,597 |
| 24-05-14 | 26.44 | +0.88% | 834,258 |
| 24-05-13 | 26.21 | +0.85% | 785,716 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotes
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.
Calendar
2024-07-23
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
27.54
USD
Average target price
33.8
USD
Spread / Average Target
+22.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -36.76% | 2.17B | |
| -5.43% | 181B | |
| +4.30% | 114B | |
| -3.09% | 68.29B | |
| +5.86% | 52.24B | |
| +8.15% | 44.3B | |
| +7.52% | 42.73B | |
| +25.54% | 32.52B | |
| +17.85% | 26.02B | |
| +1.00% | 25.91B |
- Stock Market
- Equities
- IART Stock
